Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative esketamine to reduce perioperative opioid use in laparoscopic gastrointestinal surgery
ChiCTR2200066857Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastrointestinal stromal tumor (GIST) comparing Esketamine group with Placebo group (2 arms). Primary endpoint: Perioperative sufentanil consumption. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR2200066857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066857.